Patent ID: 9498490
Filing Date: 2016-11-22
CPC Classification: A61K,A61P,C07H,Y02A

Claim Text:
1. A method of treating disorders and diseases of the central and peripheral nervous systems, comprising administering to a patient in need thereof a pharmaceutical composition comprising a therapeutically effective amount of a porcine monosialoganglioside GM1 produced according to a process for the purification of monosialoganglioside GM1 comprising separating monosialoganglioside GM1 from Fucosyl-GM1 in a lipidic mixture containing the monosialoganglioside GM1 as the main ganglioside component, by ion exchange column-chromatography using an eluent comprising potassium or caesium ions, wherein said porcine monosialoganglioside GM1 comprises less than 0.1% Fuc-GM1.